Carcinogenesis Advance Access originally published online on February 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 25, No. 7, 1219-1226,
July 2004
Carcinogenesis vol.25 no.7 © Oxford University Press 2004; all rights reserved.
ARTICLE |
APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study
1 Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Department of Epidemiology, 2 Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Department of Pathology and 3 Research Institute Growth and Development (GROW), Department of Pathology, University Maastricht, 6200 MD Maastricht and 4 TNO Nutrition and Food Research, 3700 AJ Zeist, The Netherlands
5 To whom correspondence should be addressed Email: m.luchtenborg{at}epid.unimaas.nl
The adenomatous polyposis coli (APC) gene is considered to be a gatekeeper in colorectal tumourigenesis. Inactivating mutations in APC have been reported in 34–70% of sporadic colorectal cancer patients, the majority of which occur in the mutation cluster region (MCR). In this study, tumour tissue from 665 incident colorectal cancer patients, who originate from 120 852 men and women (55–69 years of age at baseline) participating in The Netherlands Cohort Study, was evaluated for the occurrence and type of APC mutations with regard to age at diagnosis, gender, family history of colorectal cancer, Dukes' stage, tumour differentiation and sub-localization. Mutation analysis of the MCR, which spans codons 1286–1513, was performed on archival adenocarcinoma samples using macrodissection, nested PCR and direct sequencing of purified PCR fragments. A large number of genetic aberrations (n = 978), including point mutations (n = 833), deletions (n = 126) and insertions (n = 19) was detected in the MCR in 72% of patients (479/665). In particular, we observed a large number of missense mutations, more than reported previously. This may indicate involvement in colorectal carcinogenesis, although their significance for APC functions is unclear. Truncating mutations were found in 37% of patients (248/665). Patients with rectosigmoid and rectum tumours relatively more frequently harboured C > T nonsense mutations and truncating frameshift mutations as compared with patients with proximal and distal colon tumours (P = 0.009 and P = 0.045, respectively). Differences in occurrence of truncating mutations with regard to tumour sub-localization suggest a different aetiology of tumourigenesis in colon and rectum.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Mutoh, N. Niho, M. Komiya, M. Takahashi, R. Ohtsubo, K. Nakatogawa, K. Ueda, T. Sugimura, and K. Wakabayashi Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice Carcinogenesis, April 1, 2008; 29(4): 824 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kuijsten, P. C. H. Hollman, H. C. Boshuizen, M. N. C. P. Buijsman, P. van 't Veer, F. J. Kok, I. C. W. Arts, and H. B. Bueno-de-Mesquita Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study Am. J. Epidemiol., March 15, 2008; 167(6): 734 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Lips, R. van Eijk, E. J.R. de Graaf, P. G. Doornebosch, N. F.C.C. de Miranda, J. Oosting, T. Karsten, P. H.C. Eilers, R. A.E.M. Tollenaar, T. van Wezel, et al. Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer Clin. Cancer Res., February 1, 2008; 14(3): 772 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sanchez-de-Abajo, M. de la Hoya, M. van Puijenbroek, A. Tosar, J.A. Lopez-Asenjo, E. Diaz-Rubio, H. Morreau, and T. Caldes Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways Clin. Cancer Res., October 1, 2007; 13(19): 5729 - 5735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Femia, P. Dolara, A. Giannini, M. Salvadori, A. Biggeri, and G. Caderni Frequent Mutation of Apc Gene in Rat Colon Tumors and Mucin-Depleted Foci, Preneoplastic Lesions in Experimental Colon Carcinogenesis Cancer Res., January 15, 2007; 67(2): 445 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. de Vogel, M. van Engeland, M. Luchtenborg, A. P. de Bruine, G. M. J. M. Roemen, M. H. F. M. Lentjes, R. A. Goldbohm, P. A. van den Brandt, A. F. P. M. de Goeij, and M. P. Weijenberg Dietary Folate and APC Mutations in Sporadic Colorectal Cancer J. Nutr., December 1, 2006; 136(12): 3015 - 3021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Nielsen, J W Poley, S Verhoef, M van Puijenbroek, M M Weiss, G T Burger, C J Dommering, H F A Vasen, E J Kuipers, A Wagner, et al. Duodenal carcinoma in MUTYH-associated polyposis J. Clin. Pathol., November 1, 2006; 59(11): 1212 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G R van den Brink and J C H Hardwick Hedgehog Wnteraction in colorectal cancer Gut, July 1, 2006; 55(7): 912 - 914. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sugai, W. Habano, Y.-F. Jiao, M. Tsukahara, Y. Takeda, K. Otsuka, and S.-i. Nakamura Analysis of Molecular Alterations in Left- and Right-Sided Colorectal Carcinomas Reveals Distinct Pathways of Carcinogenesis: Proposal for New Molecular Profile of Colorectal Carcinomas J. Mol. Diagn., May 1, 2006; 8(2): 193 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Luchtenborg, M. P. Weijenberg, E. Kampman, G. N. van Muijen, G. M. J. M. Roemen, M. P. A. Zeegers, R. A. Goldbohm, P. van 't Veer, A. F. P. M. de Goeij, and P. A. van den Brandt Cigarette Smoking and Colorectal Cancer: APC Mutations, hMLH1 Expression, and GSTM1 and GSTT1 Polymorphisms Am. J. Epidemiol., May 1, 2005; 161(9): 806 - 815. [Abstract] [Full Text] [PDF]
|
|